Company Filing History:
8 out of 13 
3 out of 7 
2 out of 3 Years Active: 2014-2023
Title: Biography of David Robert Micklem
Introduction: David Robert Micklem is a prominent inventor based in Bergen, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting the Axl protein. With a total of 11 patents to his name, Micklem's work has the potential to impact various therapeutic applications.
Latest Patents: Among his latest patents are the "Anti-Axl antagonistic antibodies," which relate to antibodies that specifically bind to a novel epitope on the Axl protein. This patent also includes methods for the production and use of these anti-Axl antibodies. Another notable patent is also titled "Anti-Axl antagonistic antibodies," which describes antibodies that inhibit the interaction between Axl and its ligand, Gas6, along with methods for their production and use.
Career Highlights: Throughout his career, Micklem has worked with notable companies such as Bergenbio ASA, where he has contributed to innovative research and development in the field of biotechnology. His expertise in antibody development has positioned him as a key figure in his industry.
Collaborations: David Robert Micklem has collaborated with esteemed colleagues, including Linn Nilsson and Sergej Kiprijanov. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.
Conclusion: David Robert Micklem's contributions to biotechnology through his patents